Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 14, 2011; 17(2): 181-190
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.181
Published online Jan 14, 2011. doi: 10.3748/wjg.v17.i2.181
LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway
Jie Liu, Xue-Qiong Fu, Wei Zhou, Institute of Gastroenterology and Hepatology, Wuhan University Medical School, Wuhan 430060, Hubei Province, China
Hong-Gang Yu, Jie-Ping Yu, He-Sheng Luo, Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China
Author contributions: Liu J, Zhou W and Fu XQ performed the majority of experiments; Yu HG provided vital reagents and analytical tools and was also involved in editing the manuscript; Luo HS and Yu JP designed the study and provided financial support for this work; Liu J wrote the manuscript.
Supported by The National Natural Science Foundation of China, No. 30470782
Correspondence to: He-Sheng Luo, Professor, Department of Gastroenterology, Renmin Hospital of Wuhan University, 238 Jiefang Street, Wuhan 430060, Hubei Province, China. luotangwh@gmail.com
Telephone: +86-27-88042134 Fax: +86-27-88042292
Received: September 14, 2010
Revised: December 14, 2010
Accepted: December 21, 2010
Published online: January 14, 2011
Revised: December 14, 2010
Accepted: December 21, 2010
Published online: January 14, 2011
Core Tip